Cytokinetics, Incorporated · NASDAQ:CYTK

Lee Sung sold 1,112 Cytokinetics, Incorporated shares (Form 4)

Traded Jul 1, 2026 · Filed Jul 2, 2026

On Jul 1, 2026, Lee Sung (EVP, Chief Financial Officer) sold 1,112 Cytokinetics, Incorporated shares at US$87.79 for US$97,622 under a trading plan, leaving 63,221 shares. Filed Jul 2, 2026 (Form 4).

Sold
1,112 shares
Price
US$87.79
Value
US$97,622
Holding after
63,221 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP, Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 1, 2026Common StockOption exercise1,112US$48.5164,333Direct
Jul 1, 2026Common StockSale1,112US$87.7963,221Direct

Source

View original at SEC

Related